BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olson JC. Intensive Care Management of Patients with Cirrhosis. Curr Treat Options Gastroenterol 2018;16:241-52. [PMID: 29616404 DOI: 10.1007/s11938-018-0182-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Zhou J, Li Q, Xu J, Qi J, Bian H. The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation. Biomed Pharmacother 2018;106:83-91. [PMID: 29957470 DOI: 10.1016/j.biopha.2018.06.102] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
2 Kubesch A, Peiffer KH, Abramowski H, Dultz G, Graf C, Filmann N, Zeuzem S, Bojunga J, Friedrich-Rust M. The presence of liver cirrhosis is a strong negative predictor of survival for patients admitted to the intensive care unit - Cirrhosis in intensive care patients. Z Gastroenterol 2021;59:657-64. [PMID: 33728617 DOI: 10.1055/a-1401-2387] [Reference Citation Analysis]